BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9763087)

  • 1. Prognostic significance of subclassification of stage IIB lung cancer: a retrospective study of 226 patients.
    Yin N; Ha M; Liu Y; Gu H; Zhang Z; Liu W
    Oncotarget; 2017 Jul; 8(28):45777-45783. PubMed ID: 28501856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer.
    Jung J; Suh YJ; Ko BK; Lee ES; Kim EK; Paik NS; Byun KD; Hwang KT
    Cancer Med; 2018 Nov; 7(11):5514-5524. PubMed ID: 30311421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New horizons in prostate cancer imaging.
    Ravizzini G; Turkbey B; Kurdziel K; Choyke PL
    Eur J Radiol; 2009 May; 70(2):212-26. PubMed ID: 18993004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients.
    Balázs K; Antal L; Sáfrány G; Lumniczky K
    J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33924671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Current status and future outlook of ultrasound treatment for prostate cancer.
    Shoji S; Naruse J; Oda K; Kuroda S; Umemoto T; Nakajima N; Hasegawa M; Mukasa A; Koizumi N; Miyajima A
    J Med Ultrason (2001); 2024 Mar; ():. PubMed ID: 38548940
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?
    Cabrera AR; Coakley FV; Westphalen AC; Lu Y; Zhao S; Shinohara K; Carroll PR; Kurhanewicz J
    Radiology; 2008 May; 247(2):444-50. PubMed ID: 18430877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system].
    Hammerer PG; Augustin H; Blonski J; Graefen M; Haese A; Erbersdobler A; Daghofer F; Huland H
    Urologe A; 2004 Mar; 43(3):307-12. PubMed ID: 15045191
    [No Abstract]   [Full Text] [Related]  

  • 8. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients.
    Crook JM; Perry GA; Robertson S; Esche BA
    Urology; 1995 Apr; 45(4):624-31; discussion 631-2. PubMed ID: 7716843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
    Epstein JI; Walsh PC; Brendler CB
    J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy.
    Liebross RH; Pollack A; Lankford SP; von Eschenbach AC; Zagars GK
    Urology; 1998 Oct; 52(4):647-52. PubMed ID: 9763087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.
    Pinover WH; Hanlon A; Lee WR; Kaplan EJ; Hanks GE
    Cancer; 1996 Apr; 77(7):1334-41. PubMed ID: 8608512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy: an evaluation based on disease outcome.
    Liebross RH; Pollack A; Lankford SP; Zagars GK; von Eschenbach AC; Geara FB
    Cancer; 1999 Apr; 85(7):1577-85. PubMed ID: 10193949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy.
    Zagars GK; Geara FB; Pollack A; von Eschenbach AC
    Cancer; 1994 Apr; 73(7):1904-12. PubMed ID: 7511040
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.